Arnold M, Koerner U, Remonda L, Nedeltchev K, Mattle H P, Schroth G, Sturzenegger M, Weber J, Koerner F
Department of Neurology, University of Berne, Freiburgstrasse, Inselspital, CH-3010 Berne, Switzerland.
J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):196-9. doi: 10.1136/jnnp.2004.037135.
Several case series and a recent meta-analysis indicate that intra-arterial thrombolysis (IAT) is effective for the treatment of acute central retinal artery occlusion (CRAO).
A total of 37 patients with acute monocular blindness because of unilateral thromboembolic CRAO were treated with IAT using urokinase within six hours of the onset of symptoms. Visual outcome was compared with a control group of 19 patients, also seen within six hours, who did not undergo thrombolytic treatment. In both groups some patients were treated by paracentesis and/or acetazolamide. Predictors of visual outcome were evaluated.
Visual improvement was more likely with IAT (p = 0.01) as were the chances to regain visual acuity of >0.6 significantly better (p = 0.04): 8/37 patients (22%) regained visual acuity of >0.6 in the IAT group and none (0/19) in the control group. Younger patients were more likely to regain some vision with (p = 0.012) or without IAT (p = 0.026). Three patients had minor treatment related cerebral ischaemic events, two had transient ischaemic attacks and one a minor stroke. There were no haemorrhagic complications.
This series of patients with CRAO demonstrated that IAT enhanced the chances of visual improvement compared with conventional treatment only. Furthermore, younger patients have a better chance to achieve some visual recovery.
多个病例系列研究及近期一项荟萃分析表明,动脉内溶栓(IAT)对急性视网膜中央动脉阻塞(CRAO)的治疗有效。
共有37例因单侧血栓栓塞性CRAO导致急性单眼失明的患者在症状发作6小时内接受了使用尿激酶的IAT治疗。将视力结果与19例同样在6小时内就诊但未接受溶栓治疗的对照组患者进行比较。两组中部分患者接受了前房穿刺和/或乙酰唑胺治疗。对视力结果的预测因素进行了评估。
IAT组视力改善的可能性更大(p = 0.01),视力恢复至>0.6的几率也显著更高(p = 0.04):IAT组中8/37例患者(22%)视力恢复至>0.6,而对照组中无一例(0/19)恢复至该水平。年轻患者无论是否接受IAT治疗,恢复部分视力的可能性更大(接受IAT治疗时p = 0.012,未接受IAT治疗时p = 0.026)。3例患者出现了与治疗相关的轻微脑缺血事件,2例发生短暂性脑缺血发作,1例发生轻度中风。未出现出血性并发症。
这组CRAO患者表明,与单纯传统治疗相比,IAT提高了视力改善的几率。此外,年轻患者实现一定程度视力恢复的机会更大。